(Q41409747)

30 September 2017

Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease (English)

1 reference

30 September 2017

0 references

8

B Winblad

1 reference

30 September 2017

9

J Hardy

1 reference

30 September 2017

P Foley

1

1 reference

30 September 2017

H F Bradford

2

1 reference

30 September 2017

M Docherty

3

1 reference

30 September 2017

H Fillit

4

1 reference

30 September 2017

V N Luine

5

1 reference

30 September 2017

B McEwen

6

1 reference

30 September 2017

G Bucht

7

1 reference

30 September 2017

1 November 1988

1 reference

30 September 2017

1 reference

30 September 2017

235

1 reference

30 September 2017

8

1 reference

30 September 2017

466-471

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00314249

30 September 2017

0 references

cites work

An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease

1 reference

12 December 2020

The Global Deterioration Scale for assessment of primary degenerative dementia

1 reference

12 December 2020

Evidence for specific immunolysis of nerve terminals using antisera against choline acetyltransferase, glutamate decarboxylase and tyrosine hydroxylase.

1 reference

12 December 2020

Depolarizing stimuli and the release of physiologically active amino acids from suspensions of mammalian synaptosomes

1 reference

12 December 2020

The significance of anti-neuronal antibodies in Alzheimer's disease

1 reference

12 December 2020

A simple and sensitive assay for dopamine-beta-hydroxylase.

1 reference

12 December 2020

Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.

1 reference

12 December 2020

Antibodies in cerebrospinal fluid of some Alzheimer disease patients recognize cholinergic neurons in the rat central nervous system

1 reference

12 December 2020

Clinical subtypes of dementia of the Alzheimer type

1 reference

12 December 2020

Evidence for Blood-Brain Barrier Changes in Senile Dementia of the Alzheimer Type (SDAT)

1 reference

12 December 2020

1 reference

12 December 2020

Specific lysis of noradrenergic synaptosomes by an antiserum to dopamine-beta-hydroxylase.

1 reference

12 December 2020

"Autocannibalism" of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease-A hypothesis.

1 reference

12 December 2020

Presynaptic cholinergic dysfunction in patients with dementia.

1 reference

12 December 2020

Changes in the brain catecholamines in patients with dementia of Alzheimer type.

1 reference

12 December 2020

Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type.

1 reference

12 December 2020

Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities

1 reference

12 December 2020

A cell-surface antigen of cholinergic nerve terminals recognized by antisera to choline acetyltransferase.

1 reference

12 December 2020

Transmitter deficits in Alzheimer's disease

1 reference

12 December 2020

The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00314249

1 reference

30 September 2017

1 reference